Synonyms: enzalutamide; MDV 3100; XTANDI; C540278; 4-[3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methylbenzamide; Enzalutamide (MDV3100); MDV3100 (Enzalutamide); UNII-93T0T9GKNU; MDV3100 Enzalutamide; 93T0T9GKNU; CHEBI:68534; 4-{3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl}-2-fluoro-N-methylbenzamide; 4-{3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl}-2-fluoro-N-methylbenzamide; 4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-imidazolidin-1-yl]-2-fluoro-N-methyl-benzamide; MDV-3100; Benzamide,4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methyl-; Enzalutamide [USAN:INN]; 4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-fluoro-N-methylbenzamide; Xtandi (TN); PubChem19320; Tube704; Enzalutamide (JAN/USAN); MDV3100, AldrichCPR; MLS006010067; SCHEMBL189749; MDV3100; GTPL6812; C21H16F4N4O2S; CHEMBL1082407; CTK8B6725; EX-A046; QCR-130; WXCXUHSOUPDCQV-UHFFFAOYSA-N; BCPP000169; HMS3654L07; NC-54; Enzalutamide; AMX10212; AOB87731; ASP-9785; MDV3100/MDV-3100; ABP000459; ANW-54164; BBL102957; BDBM50425732; MFCD14155804; s1250; 915087-33-1; STL556766; ZINC34806477; AKOS015851022; ACN-026804; API0007596; BCP9000901; CS-0317; DB08899; RL05765; SB20413; MDV3100; KS-0000079W; NCGC00263120-01; AC-26924; AK-72825; AN-16279; AS-17047; BC660065; BR-72825; CJ-18592; HY-70002; MDV-3100; MDV3100, 95%; SC-69109; SMR004701227; AB0008149; AX8165432; TC-142909; FT-0670957; ST24028748; SW219288-1; W9480; 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluoro-N-methylbenzamide; A25302; D10218; S-3847; AB01565849_02; SR-01000941580; J-519668; SR-01000941580-1; BRD-K56851771-001-01-9; MDV-3100, 915087-33-1; 4-(3-(4-Cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluoro-N-me; MDV 3100; Benzamide, 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl)-2-fluoro-N-methyl-; n-methyl-4-[3-(4-cyano-3-trifluoromethylphenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl]-2-fluo; Enzalutamide [USAN]; D0M1YR; D0QK5X; Enzalutamide (AR inhibitor); cc-412; MDV3101; A3003; A10562;